199 related articles for article (PubMed ID: 32584842)
21. Magnetic resonance imaging of the efficacy of specific inhibition of 5 alpha-reductase in canine spontaneous benign prostatic hyperplasia.
Cohen SM; Taber KH; Malatesta PF; Shpungin J; Berman C; Carlin JR; Werrmann JG; Prahalada S; Bryan RN; Cordes EH
Magn Reson Med; 1991 Sep; 21(1):55-70. PubMed ID: 1719333
[TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of the GnRH agonist (deslorelin) in dogs affected by benign prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound.
Polisca A; Orlandi R; Troisi A; Brecchia G; Zerani M; Boiti C; Zelli R
Reprod Domest Anim; 2013 Aug; 48(4):673-80. PubMed ID: 23320475
[TBL] [Abstract][Full Text] [Related]
23. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
[TBL] [Abstract][Full Text] [Related]
24. Effect of osaterone acetate administration on prostatic regression rate, peripheral blood hormone levels and semen quality in dogs with benign prostatic hypertrophy.
Tsutsui T; Hori T; Shimizu M; Tatsuzawa C; Kawakami E
J Vet Med Sci; 2001 Apr; 63(4):453-6. PubMed ID: 11346183
[TBL] [Abstract][Full Text] [Related]
25. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.
Gormley GJ; Stoner E; Bruskewitz RC; Imperato-McGinley J; Walsh PC; McConnell JD; Andriole GL; Geller J; Bracken BR; Tenover JS
N Engl J Med; 1992 Oct; 327(17):1185-91. PubMed ID: 1383816
[TBL] [Abstract][Full Text] [Related]
26. Effect of dual inhibition of 5-alpha-reductase and aromatase on spontaneously developed canine prostatic hypertrophy.
Suzuki K; Okazaki H; Ono Y; Kurokawa K; Suzuki T; Onuma E; Takanashi H; Mamiya Y; Yamanaka H
Prostate; 1998 Oct; 37(2):70-6. PubMed ID: 9759700
[TBL] [Abstract][Full Text] [Related]
27. Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? PLESS Study Group. Proscar Long-Term Efficacy and Safety Study.
Yang XJ; Lecksell K; Short K; Gottesman J; Peterson L; Bannow J; Schellhammer PF; Fitch WP; Hodge GB; Parra R; Rouse S; Waldstreicher J; Epstein JI
Urology; 1999 Apr; 53(4):696-700. PubMed ID: 10197843
[TBL] [Abstract][Full Text] [Related]
28. Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs.
Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
BMC Vet Res; 2019 Dec; 15(1):440. PubMed ID: 31805935
[TBL] [Abstract][Full Text] [Related]
29. Effects of an extract of Serenoa repens on dogs with hyperplasia of the prostate gland.
Barsanti JA; Finco DR; Mahaffey MM; Fayrer-Hosken RA; Crowell WA; Thompson FN; Shotts EB
Am J Vet Res; 2000 Aug; 61(8):880-5. PubMed ID: 10951976
[TBL] [Abstract][Full Text] [Related]
30. Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate.
Canda AE; Mungan MU; Yilmaz O; Yorukoglu K; Tuzel E; Kirkali Z
Int Urol Nephrol; 2006; 38(2):275-80. PubMed ID: 16868697
[TBL] [Abstract][Full Text] [Related]
31. Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model.
Tutrone RF; Ball RA; Ornitz DM; Leder P; Richie JP
J Urol; 1993 Mar; 149(3):633-9. PubMed ID: 7679760
[TBL] [Abstract][Full Text] [Related]
32. Blood dripping from the penis of a German Shepherd dog.
Sontas BH; Milani C; Mollo A; Romagnoli S
Aust Vet J; 2010 Jun; 88(6):242-4. PubMed ID: 20553576
[No Abstract] [Full Text] [Related]
33. Cystic endometrial hyperplasia-pyometra syndrome in bitches: identification of hemodynamic, inflammatory, and cell proliferation changes.
Veiga GA; Miziara RH; Angrimani DS; Papa PC; Cogliati B; Vannucchi CI
Biol Reprod; 2017 Jan; 96(1):58-69. PubMed ID: 28395328
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the possibility of using biomarkers (CCL11 and TGF-beta 1) in the diagnosis of prostate gland hyperplasia in dogs.
Krakowski L; WieszczeczyĆski M; Furmaga J; Krakowska I; Opielak G; Brodzki P; Piech T; Grodzka M; DomagaĆa D; Furmaga O; Rokos C
Theriogenology; 2022 Oct; 192():9-13. PubMed ID: 36030614
[TBL] [Abstract][Full Text] [Related]
35. Quantitative evaluation of glandular and stromal compartments in hyperplastic dog prostates: effect of 5-alpha reductase inhibitors.
Laroque PA; Prahalada S; Molon-Noblot S; Cohen SM; Soper K; Duprat P; Peter CP; van Zwieten MJ
Prostate; 1995 Sep; 27(3):121-8. PubMed ID: 7567690
[TBL] [Abstract][Full Text] [Related]
36. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
37. Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasia.
Stoner E
Urology; 1994 Mar; 43(3):284-92; discussion 292-4. PubMed ID: 7510911
[TBL] [Abstract][Full Text] [Related]
38. Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
Kaya C; Ozyurek M; Turkeri LN
Int J Urol; 2005 Feb; 12(2):194-8. PubMed ID: 15733115
[TBL] [Abstract][Full Text] [Related]
39. Perfusion change in benign prostatic hyperplasia before and after castration in a canine model: Contrast enhanced ultrasonography and CT perfusion study.
Yoon S; Alfajaro MM; Cho KO; Choi US; Je H; Jung J; Jang Y; Choi J
Theriogenology; 2020 Oct; 156():97-106. PubMed ID: 32682181
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.
Palmieri C
Vet Pathol; 2015 Jul; 52(4):607-13. PubMed ID: 25281650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]